This paper examines the correlation between axillary lymph node status and primary tumour characteristics in breast cancer and whether this can be used to select patients for axillary lymphadenectomy. The results are based on a retrospective analysis of 909 patients who underwent axillary dissection in our unit. Axillary lymph nodes containing metastases were found in 406 patients (44.7%), all with invasive carcinomas, but in none of the 37 carcinomas-in-situ. Nodal status was negative in all T1a tumours, but lymph node metastases were present in 16.3% and 35.7% of T1b and T1c tumours respectively. When histological grade was taken into account, positivity for grade I T1b and T1c tumours fell to 13.6% and 26.7% respectively. Lymph node metastases were found in 85% of patients with lymphovascular invasion in their tumours as compared to only 15.4% of those without and in 45.5% of oestrogen and progesterone receptor-positive tumours. When one or both hormone receptors were absent this figure was much higher. It appears that for T1a breast cancers axillary dissection is not necessary, whereas for T1b, T1c and grade I T2 tumours other histopathological parameters should be taken into consideration in deciding who should undergo axillary lymphadenectomy.
Albertini, J. J., Lyman, G. H., Cox, C., Yeatman, T. & Balducci, L. et al (1996). Lymphatic mapping and sentinel lymph node biopsy in the patient with breast cancer. JAMA 276: 1818–1822.
Avril, N., Dose, J., Janicke, F., Ziegler, S., Romer, W., Weber, W., Herz, M., Nathrath, W., Graeff, H. & Schwaiger, M. (1996). Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst 88: 1204–1209.
Barth, A., Craig, P. H. & Silverstein, M. J. (1997). Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79: 1918–1922.
Benson, E. A. & Thorogood, J. (1986). The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 12: 267–271.
Bruneton, J. N., Caramella, E. & Hery, M. et al (1986). Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 158: 325–326.
Cabanas, R. M. (1977). An approach for the treatment of penile carcinoma. Cancer 39: 456–466.
Cabanes, P. A., Salmon, R. J., Vilcoq, J. R., Durand, J. C., Fourquet, A. & Gautier, C. Asselain B., for the breast carcinoma collaborative group of the Institut Curie (1992). Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339: 1245–1248.
Cady, B. (1997). Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer 79: 1856–1861.
Crowe, J. P., Gordon, N. H., Shenk, R. R., Zollinger, R. M., Brumberg, D. J. & Shuck, J. M. (1992). Primary tumour size: relevance to breast cancer survival. Arch Surg 127: 910–916.
Dowlatshahi, K., Fan, M., Snider, H. C. & Habib, F. A. (1997). Lymph node micrometastases from breast carcinoma. Cancer 80: 1188–1197.
Elston, C. W. & Ellis, I. O. (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 19: 403–410.
Fentiman, I. S. & Mansel, R. E. (1991). The axilla: not a no-go zone. Lancet 337: 221–223.
Fisher, B., Slack, N. H. & Bross, I. D. J. et al (1969). Cancer of the breast: size of neoplasm and prognosis. Cancer 24: 1071–1080.
Fisher, B., Redmond, C., Fisher, E. R., Bauer, M., Wolmark, N. & Wickerham, L. et al (1985). Ten-year results of a randomised clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674–681.
Giuliano, A. E., Kirgan, D. M., Guenther, J. M. & Morton, D. L. (1994). Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391–401.
Giuliano, A. E., Dale, P. S., Turner, R. R., Morton, D. L., Evans, S. W. & Kranse, D. L. (1995). Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394–401.
Greenall, M. J. (1995). Why I favour axillary node sampling in the management of breast cancer. Eur J Surg Oncol 21: 2–5.
Gutman, H., Kersz, T. & Barzilai, T. et al (1990). Achievements of physical therapy in patients after modified radical mastectomy compared with quadrantectomy, axillary dissection, and radiation for carcinoma of the breast. Arch Surg 125: 389–391.
Harris, J. R. & Osteen, R. T. (1985). Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5: 17–21.
Hayward, J. L. & Caleffi, M. (1987). The significance of local control in the primary treatment of breast cancer. Arch Surg 122: 1244–1247.
Hoe, A. L., Iven, D., Royle, G. T. & Taylor, I. (1992). Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 79: 261–262.
Kissin, M. W., Thompson, E. M., Price, A. B., Slavin, G. & Kark, A. E. (1982). The inadequecy of axillary sampling in breast cancer. Lancet i: 1210–1211.
Kjaergaard, J., Blichert-Toft, M. & Anderson, J. (1985). Probability of false negative nodal status in conjunction with partial axillary dissection in breast cancer. Br J Surg 72: 365–367.
Krag, D. N., Weaver, D. L., Alex, J. C. & Fairbank, J. T. (1983). Surgical resection and radiolocalisation of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993: 335–339.
Lam, W. W., Yang, W. T., Chan, Y. L., Stewart, I. E., Metreweli, C. & King, W. (1996). Detection of axillary lymph node metestases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 23: 498–503.
Lauria, R., Perrone, F., Carlomagno, C., De-Laurentiis, M., Morabito, A., Gallo, C., Varriale, E., Pettinato, G., Panico, L. & Petrella, G. et al (1995). The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 76: 1772–1778.
McGuckin, M. A., Cummings, M. C., Walsh, M. D., Hohn, B. G., Bennett, I. C. & Wright, R. G. (1996). Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73: 88–95.
McLean, R. G. & Ege, G. N. (1986). Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J Nucl Med 27: 1116–1124.
Morton, D., Wen, D. & Cochran, A. (1992). Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or ‘watch and wait’. Surg Oncol Clin N Am 1: 247–259.
Roberti, N. E. (1997). The role of histologic grading in the prognosis of patients with carcinoma of the breast. Cancer 80: 1708–1716.
Sacre, R. A. (1986). Clinical evaluation of axillary lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 12: 169–173.
Silverstein, M. J., Gierson, E. D., Waisman, J. R., Senofsky, G. M., Colburn, W. J. & Gamagami, P. (1994). Axillary lymph node dissection for T1a breast carcinoma. Cancer 73: 664–667.
Steele, R. J. C., Forrest, A. P. M. & Gibson, T. et al (1985). The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomised trial. Br J Surg 72: 368–369.
Tjandra, J. J., Russell, I. S., Collins, J. P., Andrews, J. T., Lichtenstein, M., Binns, D. & McKenzie, I. F. (1989a). Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer. Cancer Res 49: 1600–1608.
Tjandra, J. J., Sacks, N. P., Thompson, C. H., Leyden, M. J., Stacker, S. A., Lichtenstein, M., Russell, I. S., Collins, J. P., Andrews, J. T. & Pietersz, G. A. et al (1989b). The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study. Br J Cancer 59: 296–302.
Veronesi, U., Paganelli, G., Galimberti, V., Viale, G., Zurrida, S., Bedoni, M., Costa, A., de Cicco, C., Geraghty, J. G., Luini, A., Szcchini, V. & Veronesi, P. (1997). Sentinel- node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864–1867.
About this article
Cite this article
Yiangou, C., Shousha, S. & Sinnett, H. Primary tumour characteristics and axillary lymph node status in breast cancer. Br J Cancer 80, 1974–1978 (1999). https://doi.org/10.1038/sj.bjc.6690629
- axillary lymph nodes
- breast cancer
- primary tumour characteristics
Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?
Value of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma
Indian Journal of Surgical Oncology (2010)
Breast Cancer Research and Treatment (2008)
Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer
Modern Pathology (2007)
Breast Cancer Research and Treatment (2006)